AAAAAA
Results:
1-14
|
Results: 14
Authors:
BOW EJ
Citation: Ej. Bow, INFECTION RISK AND CANCER-CHEMOTHERAPY - THE IMPACT OF THE CHEMOTHERAPEUTIC REGIMEN IN PATIENTS WITH LYMPHOMA AND SOLID TISSUE MALIGNANCIES, Journal of antimicrobial chemotherapy, 41, 1998, pp. 1-5
Authors:
BOW EJ
GALLANT G
WILLIAMS GJ
WOLOSCHUK D
SHORE TB
RUBINGER M
SCHACTER BA
Citation: Ej. Bow et al., REMISSION INDUCTION THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA USINGA NON-CYTARABINE-CONTAINING REGIMEN OF IDARUBICIN, ETOPOSIDE, AND CARBOPLATIN, Cancer, 83(7), 1998, pp. 1344-1354
Authors:
BOW EJ
Citation: Ej. Bow, INVASIVE FUNGAL-INFECTIONS IN PATIENTS RECEIVING INTENSIVE CYTOTOXIC THERAPY FOR CANCER, British Journal of Haematology, 101, 1998, pp. 1-4
Authors:
BOW EJ
LOEWEN R
CHEANG MS
SHORE TB
RUBINGER M
SCHACTER B
Citation: Ej. Bow et al., CYTOTOXIC THERAPY-INDUCED D-XYLOSE MALABSORPTION AND INVASIVE INFECTION DURING REMISSION-INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA IN ADULTS, Journal of clinical oncology, 15(6), 1997, pp. 2254-2261
Authors:
BOW EJ
Citation: Ej. Bow, GRAM-POSITIVE INFECTIONS AND QUINOLONES IN NEUTROPENIA - RESPONSE, Annals of internal medicine, 126(10), 1997, pp. 831-831
Authors:
BOW EJ
SUTHERLAND JA
KILPATRICK MG
WILLIAMS GJ
CLINCH JJ
SHORE TB
RUBINGER M
SCHACTER BA
Citation: Ej. Bow et al., THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - REMISSION-INDUCTION USING A NON-CYTARABINE-CONTAINING REGIMEN OF MITOXANTRONE PLUS ETOPOSIDE, Journal of clinical oncology, 14(4), 1996, pp. 1345-1352
Authors:
MOLTZAN C
BOW EJ
LOEWEN R
FREED B
Citation: C. Moltzan et al., ACYCLOVIR (ACV) PROPHYLAXIS AGAINST HERPES-SIMPLEX MUCOSITIS (HSV-M) IN ELDERLY PATIENTS RECEIVING INDUCTION THERAPY FOR UNTREATED ACUTE MYELOID-LEUKEMIA (AML), Blood, 88(10), 1996, pp. 316-316
Authors:
ROTSTEIN C
BOW EJ
LAVERDIERE M
CARR D
MOGHADDAM N
IOANNOU S
Citation: C. Rotstein et al., A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF FLUCONAZOLE (F) PROPHYLAXIS FOR FUNGAL INFECTION IN NEUTROPENIC CANCER-PATIENTS (PTS), Blood, 88(10), 1996, pp. 1694-1694
Authors:
BOW EJ
MANDELL LA
LOUIE TJ
FELD R
PALMER M
ZEE B
PATER J
Citation: Ej. Bow et al., QUINOLONE-BASED ANTIBACTERIAL CHEMOPROPHYLAXIS IN NEUTROPENIC PATIENTS - EFFECT OF AUGMENTED GRAM-POSITIVE ACTIVITY ON INFECTIOUS MORBIDITY, Annals of internal medicine, 125(3), 1996, pp. 183
Authors:
BOW EJ
LOEWEN R
CHEANG MS
SCHACTER B
Citation: Ej. Bow et al., INVASIVE FUNGAL DISEASE IN ADULTS UNDERGOING REMISSION-INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA - THE PATHOGENETIC ROLE OF THE ANTILEUKEMIC REGIMEN, Clinical infectious diseases, 21(2), 1995, pp. 361-369
Authors:
BOW EJ
LOEWEN R
VAUGHAN D
Citation: Ej. Bow et al., REQUIREMENT FOR ANTIBIOTIC-THERAPY TARGETING GRAM-NEGATIVE ORGANISMS IN FEBRILE, NEUTROPENIC PATIENTS WITH CANCER WHO ARE RECEIVING ANTIBACTERIAL CHEMOPROPHYLAXIS WITH ORAL QUINOLONES, Clinical infectious diseases, 20(4), 1995, pp. 907-912
Authors:
BOW EJ
KILPATRICK MG
SCOTT BA
CLINCH JJ
CHEANG MS
Citation: Ej. Bow et al., ACUTE MYELOID-LEUKEMIA IN MANITOBA - THE CONSEQUENCES OF STANDARD 7-INDUCTION THERAPY FOLLOWED BY HIGH-DOSE CYTARABINE POSTREMISSION CONSOLIDATION FOR MYELOSUPPRESSION, INFECTIOUS MORBIDITY, AND OUTCOME(3 REMISSION), Cancer, 74(1), 1994, pp. 52-60
Authors:
WILLIAMS GJ
BOW EJ
SUTHERLAND J
RUBINGER M
SHORE T
SCHACTER B
Citation: Gj. Williams et al., USE OF KARYOTYPIC ANALYSIS AS A PREDICTOR OF REMISSION-INDUCTION IN TREATMENT OF ACUTE MYELOID-LEUKEMIA IN THE ELDERLY, Blood, 84(10), 1994, pp. 10000628-10000628
Authors:
BOW EJ
RONALD AR
Citation: Ej. Bow et Ar. Ronald, ANTIBACTERIAL CHEMOPROPHYLAXIS IN NEUTROPENIC PATIENTS - WHERE DO WE GO FROM HERE, Clinical infectious diseases, 17(3), 1993, pp. 333-337
Risultati:
1-14
|